By Molex Incorporated (NASDAQ: MOLX) and (NASDAQ: MOLXA), a global electronic components company, today reported results for its second quarter ended December 31, 2012.
| Three Months Ended | |||||||||
| Dec 31, | Sept 30, | Dec 31, | |||||||
USD millions, except per share data | 2012 | 2012 | 2011 | ||||||
| Net revenue | $ | 967.7 | $ | 916.9 | $ | 857.6 | |||
| Net income | 70.4 | 71.3 | 64.0 | ||||||
| Earnings per share | 0.39 | 0.40 | 0.36 | ||||||
Net revenue for the December 2012 quarter was $967.7 million, an increase of 5.5% from the September 2012 quarter and 12.8% from the December 2011 quarter. In local currencies, net revenue increased 4.8% compared with the September 2012 quarter and 13.8% compared with the December 2011 quarter. Orders for the December 2012 quarter were $919.7 million, a decline of 2.6% from the September 2012 quarter and an increase of 12.8% from the December 2011 quarter.
Net income for the December 2012 quarter was $70.4 million or $0.39 per share, compared with $71.3 million, or $0.40 per share, for the September 2012 quarter and $64.0 million, or $0.36 per share, for the December 2011 quarter.
"Our results came in at the high end of our guidance range and we were particularly pleased to achieve record revenue this quarter as shipments were strong leading into the Christmas period. Bookings were weaker toward the latter part of the quarter and consistent with normal seasonal trends, were down 2.6% on a sequential basis. Our pipeline of new projects is strong and we will have a clearer view of the business trends for calendar year 2013 after Chinese New Year," stated Martin P. Slark, Chief Executive Officer.
Other financial highlights for the quarter ended December 31, 2012:
- Gross profit margin was 29.9%, compared with 29.3% in the September 2012 quarter and 30.7% in the December 2011 quarter.
- SG&A expense was $181.0 million, compared with $163.1 million in the September 2012 quarter and $163.1 million in the December 2011 quarter. The September 2012 quarter included insurance proceeds of $9.9 million related to losses incurred from the March 2011 earthquake and tsunami in Japan.
- Backlog was $404.0 million, a decrease of 9.3% from the September 2012 quarter and an increase of 16.7% from the December 2011 quarter.
- The book-to-bill ratio for the December quarter was 0.95 to 1 compared with 1.03 to 1 for the September quarter and 0.95 to 1 for the December 2011 quarter.
- Capital expenditures were $78.6 million or 8.1% of revenue.
- Inventory days outstanding was 83 days compared with 84 days in the September 2012 quarter and 91 days in the December 2011 quarter.
- Accounts receivable days outstanding was 67 days compared with 69 days in the September 2012 quarter and 71 days in the December 2011 quarter.
- The effective tax rate was 31.1%.
Outlook
Based upon current order rates and customer backlog, the Company estimates revenue in the range of $900 to $930 million for the March 2013 quarter. At this level of revenue, the Company expects earnings per share in the range of $0.33 to $0.37, assuming constant foreign currency rates, unchanged commodity prices and an effective tax rate in the range of 30% to 32%.
Earnings Conference Call Information
A conference call will be held on Wednesday, January 23, 2013 at 8:30 a.m. central time. Please dial (888) 679-8035 to participate in the call. International callers should dial (617) 213-4848. Please dial in at least five minutes prior to the start of the call and refer to participant pass code 88944879. Internet users will be able to access the webcast, including slide materials, live and in replay in the "Investors" section of the Company's website at www.molex.com. A 48-hour telephone replay will be available at approximately 10:30 a.m. central time at (888) 286-8010 or (617) 801-6888 / pass code 81162241.
Other Investor Events
Feb 12 - Goldman Sachs Technology and Internet Conference in San Francisco, CA
Forward-Looking Statements
Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those stated. Words such as "expect," "anticipate," "outlook," "forecast," "could," "project," "intend," "plan," "continue," "believe," "seek," "estimate," "should," "may," "assume," "potential," variations of such words and similar expressions are used to identify these forward-looking statements. Forward-looking statements are based on currently available information and include, among others, the discussion under "Outlook." These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Respective risks, uncertainties, and assumptions that could affect the outcome or results of operations are described in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended June 30, 2012, and the Form 10-Q for the quarter ended September 30, 2012, which is incorporated by reference and in other reports that Molex files or furnishes with the Securities and Exchange Commission.
We have based our forward-looking statements on our management's beliefs and assumptions based on information available to management at the time the statements are made. We caution you that actual outcomes and results may differ materially from what is expressed, implied, or forecast by our forward-looking statements. Reference is made in particular to forward-looking statements regarding growth strategies, industry trends, global economic conditions, success of customers, cost of raw materials, value of inventory, availability of credit, foreign currency exchange rates, labor costs, protection of intellectual property, cost reduction initiatives, acquisition synergies, manufacturing strategies, product development introduction and sales, regulatory changes, competitive strengths, income tax fluctuations, natural disasters, unauthorized access to data, government investigations and outcomes of legal proceedings. Except as required under the federal securities laws, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions, or otherwise.
Molex Incorporated is a 74-year-old global manufacturer of electronic, electrical and fiber optic interconnection systems. Based in Lisle, Illinois, USA, the Company operates 41 manufacturing locations in 15 countries. The Molex website is www.molex.com.
Editor's note: Molex is traded on the NASDAQ Global Select Market (MOLX and MOLXA) in the United States and on the London Stock Exchange. The Company's voting common stock (MOLX) is included in the S&P 500 Index.
| Molex Incorporated | ||||||
| Condensed Consolidated Balance Sheets | ||||||
(in thousands) | ||||||
| Dec. 31, | June 30, | |||||
| 2012 | 2012 | |||||
| (Unaudited) | ||||||
ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 705,047 | $ | 637,417 | ||
| Marketable securities | 11,738 | 14,830 | ||||
| Accounts receivable, less allowances of $37,681 and $37,876, respectively | 745,851 | 751,279 | ||||
| Inventories | 566,889 | 531,825 | ||||
| Deferred income taxes | 101,398 | 110,789 | ||||
| Other current assets | 33,109 | 33,098 | ||||
| Total current assets | 2,164,032 | 2,079,238 | ||||
| Property, plant and equipment, net | 1,177,342 | 1,150,549 | ||||
| Goodwill | 195,030 | 160,986 | ||||
| Non-current deferred income taxes | 48,063 | 50,038 | ||||
| Other assets | 180,130 | 170,692 | ||||
| Total assets | $ | 3,764,597 | $ | 3,611,503 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
| Current liabilities: | ||||||
| Current portion of short-term borrowings and long-term debt | $ | 115,869 | $ | 104,933 | ||
| Accounts payable | 344,997 | 355,491 | ||||
| Accrued expenses: | ||||||
| Accrued liability for unauthorized activities in Japan | 170,665 | 184,177 | ||||
| Income taxes payable | 40,876 | 35,360 | ||||
| Other | 200,084 | 212,035 | ||||
| Total current liabilities | 872,491 | 891,996 | ||||
| Other non-current liabilities | 19,700 | 18,174 | ||||
| Accrued pension and other postretirement benefits | 95,424 | 115,176 | ||||
| Long-term debt | 230,000 | 150,032 | ||||
| Total liabilities | 1,217,615 | 1,175,378 | ||||
| Commitments and contingencies | ||||||
| Total stockholders' equity | 2,546,982 | 2,436,125 | ||||
| Total liabilities and stockholders' equity | $ | 3,764,597 | $ | 3,611,503 | ||
| Molex Incorporated | ||||||||||||||||
| Condensed Consolidated Statements of Income | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Net revenue | $ | 967,735 | $ | 857,598 | $ | 1,884,656 | $ | 1,793,583 | ||||||||
| Cost of sales | 678,565 | 594,661 | 1,327,069 | 1,237,918 | ||||||||||||
| Gross profit | 289,170 | 262,937 | 557,587 | 555,665 | ||||||||||||
| Selling, general and administrative | 181,028 | 163,073 | 344,149 | 332,298 | ||||||||||||
| Unauthorized activities in Japan | 1,627 | 2,723 | 4,188 | 5,645 | ||||||||||||
| Total operating expenses | 182,655 | 165,796 | 348,337 | 337,943 | ||||||||||||
| Income from operations | 106,515 | 97,141 | 209,250 | 217,722 | ||||||||||||
| Interest (expense) income, net | (1,133 | ) | (2,094 | ) | (1,943 | ) | (3,485 | ) | ||||||||
| Other (expense) income | (3,151 | ) | 1,482 | (1,955 | ) | 1,758 | ||||||||||
| Total other (expense) income, net | (4,284 | ) | (612 | ) | (3,898 | ) | (1,727 | ) | ||||||||
| Income before income taxes | 102,231 | 96,529 | 205,352 | 215,995 | ||||||||||||
| Income taxes | 31,837 | 32,513 | 63,644 | 71,462 | ||||||||||||
| Net income | $ | 70,394 | $ | 64,016 | $ | 141,708 | $ | 144,533 | ||||||||
| Earnings per share: | ||||||||||||||||
| Basic | $ | 0.40 | $ | 0.36 | $ | 0.80 | $ | 0.82 | ||||||||
| Diluted | $ | 0.39 | $ | 0.36 | $ | 0.79 | $ | 0.82 | ||||||||
| Dividends declared per share | $ | 0.2200 | $ | 0.2000 | $ | 0.4400 | $ | 0.4000 | ||||||||
| Average common shares outstanding: | ||||||||||||||||
| Basic | 177,123 | 175,830 | 176,888 | 175,656 | ||||||||||||
| Diluted | 178,854 | 176,985 | 178,743 | 176,778 | ||||||||||||
| Molex Incorporated | ||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||
(Unaudited) | ||||||||
(in thousands) | ||||||||
| Six Months Ended | |||||||
| December 31, | ||||||||
| 2012 | 2011 | |||||||
| Operating activities: | ||||||||
| Net income | $ | 141,708 | $ | 144,533 | ||||
| Add non-cash items included in net income: | ||||||||
| Depreciation and amortization | 117,402 | 121,174 | ||||||
| Share-based compensation | 15,425 | 11,402 | ||||||
| Other non-cash items | 5,685 | 5,213 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | 5,006 | 94,400 | ||||||
| Inventories | (34,831 | ) | (26,442 | ) | ||||
| Accounts payable | (5,326 | ) | (40,976 | ) | ||||
| Other current assets and liabilities | 9,605 | (7,183 | ) | |||||
| Other assets and liabilities | (97 | ) | (10,608 | ) | ||||
| Cash provided from operating activities | 254,577 | 291,513 | ||||||
| Investing activities: | ||||||||
| Capital expenditures | (148,041 | ) | (95,055 | ) | ||||
| Acquisitions | (55,299 | ) | (24,000 | ) | ||||
| Proceeds from sales of property, plant and equipment | 3,020 | 2,202 | ||||||
| Proceeds from sales or maturities of marketable securities | 8,399 | 6,553 | ||||||
| Purchases of marketable securities | (5,081 | ) | (4,787 | ) | ||||
| Insurance proceeds and other investing activities | 9,957 | - | ||||||
| Cash used for investing activities | (187,045 | ) | (115,087 | ) | ||||
| Financing activities: | ||||||||
| Proceeds from revolving credit facility | 90,000 | 75,000 | ||||||
| Payments on revolving credit facility | (10,000 | ) | (220,000 | ) | ||||
| Proceeds from short-term loans and debt | 178,089 | - | ||||||
| Payments on short-term loans and debt | (158,620 | ) | (27,389 | ) | ||||
| Proceeds from issuance of long-term debt | - | 149,713 | ||||||
| Cash dividends paid | (116,706 | ) | (70,186 | ) | ||||
| Exercise of stock options | 4,804 | 2,630 | ||||||
| Other financing activities | (2,115 | ) | (2,087 | ) | ||||
| Cash used for financing activities | (14,548 | ) | (92,319 | ) | ||||
| Effect of exchange rate changes on cash | 14,646 | (9,370 | ) | |||||
| Net increase in cash and cash equivalents | 67,630 | 74,737 | ||||||
| Cash and cash equivalents, beginning of period | 637,417 | 532,599 | ||||||
| Cash and cash equivalents, end of period | $ | 705,047 | $ | 607,336 | ||||
Molex Incorporated
Steve Martens, VP Investor Relations
630-527-4344
